Literature DB >> 28559948

Bone Scintigraphy and Tenofovir-Induced Osteomalacia in Chronic Hepatitis B.

Alex Cheen Hoe Khoo1, Yeong Fong Lee1.   

Abstract

Tenofovir, used in the treatment of chronic hepatitis B and HIV, is known for its side effects on the kidneys and bones. We share interesting images of a patient with tenofovir-induced osteomalacia on Technetium-99 m hydroxymethyelene (Tc-99 m HDP) bone scintigraphy. Pattern recognition of this bone scintigraphy and correlation with the clinical history is essential to avoid misdiagnosis.

Entities:  

Keywords:  Hepatitis B; Osteomalacia; Tc-99 m HDP; Tenofovir

Year:  2016        PMID： 28559948      PMCID： PMC5429291          DOI： 10.1007/s13139-016-0395-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


  3 in total

Review 1.  Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.

Authors:  Andrew M Hall; Bruce M Hendry; Dorothea Nitsch; John O Connolly
Journal:  Am J Kidney Dis       Date:  2011-03-23       Impact factor: 8.860

2.  Fanconi syndrome and chronic renal failure in a chronic hepatitis B monoinfected patient treated with tenofovir.

Authors:  Pedro Magalhães-Costa; Leopoldo Matos; Pedro Barreiro; Cristina Chagas
Journal:  Rev Esp Enferm Dig       Date:  2015-07       Impact factor: 2.086

3.  Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir.

Authors:  M V Gómez Martinez; F G Gallardo; T Pirogova; J García-Samaniego
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2013-08-04       Impact factor: 1.359
  3 in total
  1 in total

1.  Impact of Tenofovir Disoproxil-Induced Fanconi Syndrome on Bone Material Quality: A Case Report.

Authors:  Benjamin Hadzimuratovic; Judith Haschka; Markus A Hartmann; Stéphane Blouin; Nadja Fratzl-Zelman; Jochen Zwerina; Roland Kocijan
Journal:  JBMR Plus       Date:  2021-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.